Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C L Marsh

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
The Journal of Urology|February 1, 1995
Use of ultrasound and cystoscopically guided pancreatic allograft biopsies and transabdominal renal allograft biopsies: safety and efficacy in kidney-pancreas transplant recipientsC S Kuhr, C L Davis, D Barr, et al.
Clinical Pharmacology and Therapeutics|July 1, 1996
First-pass metabolism of midazolam by the human intestineM F Paine, D D Shen, K L Kunze, et al.
Transplantation|January 12, 1999
Recombinant human tumor necrosis factor receptor Fc fusion protein therapy in kidney transplant recipients undergoing OKT3 induction therapyE J Novak, C M Blosch, J D Perkins, et al.
Kidney International|October 1, 1993
Expression of vascular cell adhesion molecule-1 in kidney allograft rejectionC E Alpers, K L Hudkins, C L Davis, et al.
The American Journal of Pathology|February 1, 1993
Expression of vascular cell adhesion molecule (VCAM-1) in liver and pancreas allograft rejectionC E Bacchi, C L Marsh, J D Perkins, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1994
Use of midazolam as a human cytochrome P450 3A probe: I. In vitro-in vivo correlations in liver transplant patientsK E Thummel, D D Shen, T D Podoll, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1994
Use of midazolam as a human cytochrome P450 3A probe: II. Characterization of inter- and intraindividual hepatic CYP3A variability after liver transplantationK E Thummel, D D Shen, T D Podoll, et al.
Transplantation Proceedings|April 14, 2019
Investigator Assessment of the Utility of the TruGraf Molecular Diagnostic Test in Clinical PracticeM R First, V R Peddi, R Mannon, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 20, 2016
Kidney Exchange to Overcome Financial Barriers to Kidney TransplantationM A Rees, T B Dunn, C S Kuhr, et al.
Transplantation|March 27, 1996
The pharmacokinetics of a microemulsion formulation of cyclosporine in primary renal allograft recipients. The Neoral Study GroupG Barone, C T Chang, M G Choc, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
The Journal of Urology|February 1, 1995
Use of ultrasound and cystoscopically guided pancreatic allograft biopsies and transabdominal renal allograft biopsies: safety and efficacy in kidney-pancreas transplant recipientsC S Kuhr, C L Davis, D Barr, et al.
Clinical Pharmacology and Therapeutics|July 1, 1996
First-pass metabolism of midazolam by the human intestineM F Paine, D D Shen, K L Kunze, et al.
Transplantation|January 12, 1999
Recombinant human tumor necrosis factor receptor Fc fusion protein therapy in kidney transplant recipients undergoing OKT3 induction therapyE J Novak, C M Blosch, J D Perkins, et al.
Kidney International|October 1, 1993
Expression of vascular cell adhesion molecule-1 in kidney allograft rejectionC E Alpers, K L Hudkins, C L Davis, et al.
The American Journal of Pathology|February 1, 1993
Expression of vascular cell adhesion molecule (VCAM-1) in liver and pancreas allograft rejectionC E Bacchi, C L Marsh, J D Perkins, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1994
Use of midazolam as a human cytochrome P450 3A probe: I. In vitro-in vivo correlations in liver transplant patientsK E Thummel, D D Shen, T D Podoll, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1994
Use of midazolam as a human cytochrome P450 3A probe: II. Characterization of inter- and intraindividual hepatic CYP3A variability after liver transplantationK E Thummel, D D Shen, T D Podoll, et al.
Transplantation Proceedings|April 14, 2019
Investigator Assessment of the Utility of the TruGraf Molecular Diagnostic Test in Clinical PracticeM R First, V R Peddi, R Mannon, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 20, 2016
Kidney Exchange to Overcome Financial Barriers to Kidney TransplantationM A Rees, T B Dunn, C S Kuhr, et al.
Transplantation|March 27, 1996
The pharmacokinetics of a microemulsion formulation of cyclosporine in primary renal allograft recipients. The Neoral Study GroupG Barone, C T Chang, M G Choc, et al.
Pageof 6